Contribution of Antigen-Processing Machinery Genetic Polymorphisms to Atopic Dermatitis

Area of Science:

• Immunogenetics
• Dermatology
• Molecular Biology

Background:

• Atopic dermatitis (AD) is a chronic inflammatory skin condition with complex genetic underpinnings.
• Previous research identified a link between ERAP1 gene polymorphisms and AD risk.
• The role of other antigen-presenting machinery genes in AD remains to be fully elucidated.

Purpose of the Study:

• To investigate the association of polymorphisms in immunoproteasome (LMP2, LMP7) and peptide transporter (TAP1, TAP2) genes with atopic dermatitis risk and clinical outcomes.
• To determine if specific genetic variants influence disease susceptibility or age at diagnosis.

Main Methods:

• Case-control study design.
• Genotyping of single nucleotide polymorphisms (SNPs) in ERAP1, LMP2, LMP7, TAP1, and TAP2 genes.
• Statistical analysis to assess the association between genotypes and AD risk (odds ratios) and age at diagnosis (p-values).

Main Results:

• The LMP7 rs2071543*T allele was associated with a 1.5-fold decreased risk of developing AD.
• The LMP2 rs1351383*C allele significantly reduced the mean age of AD diagnosis from 23 to 15 years.
• The TAP1 rs1135216*C allele also decreased the mean age of AD diagnosis from approximately 20 to 14 years.

Conclusions:

• Polymorphisms in immunoproteasome and peptide transporter genes play a role in atopic dermatitis pathogenesis.
• Specific variants in LMP7, LMP2, and TAP1 are associated with altered AD risk and earlier disease onset.
• These findings contribute to understanding the genetic architecture of AD and may inform future research into therapeutic targets.